Economic Burden of Fungal Diseases in the United States.

Details

• Alternative Title:
  Medical Mycology, 2025, v. 63, no. 6: Economic Burden of Fungal Diseases in the United States.
• Journal Article:
  Medical Mycology
• Personal Author:
  Benedict, Kaitlin ; Gold, Jeremy A. W. ; Chiller, Tom ; Lyman, Meghan
• Description:
  We conservatively estimated the annual US fungal disease-related economic burden as $19.4 billion, including direct medical costs ($13.4 billion) of hospitalizations (n = 133 555) and outpatient visits (n = 13.4 million), $1.7 billion from absenteeism, and $4.3 billion from deaths (n = 7288). These findings underscore the need for fungal disease surveillance, treatment, and prevention efforts.
• Content Notes:
  Author manuscript
• Subjects:
  • Humans
  • Mycoses
  • Cost of Illness
  • Health Care Costs
  • Middle Aged
  • Hospitalization
  • Adult
  • Male
  • Aged
  • Female
  More +
• Keywords:
  • mycoses
  • costs and cost analysis
  • outpatients
  • hospitalization
  • death
• Source:
  Medical Mycology, 2025, v. 63, no. 6
• DOI:
  https://doi.org/10.1093/mmy/myaf049
• ISSN:
  1369-3786 ; 1460-2709
• Pubmed ID:
  40455586
• Pubmed Central ID:
  PMC12281149
• Document Type:
  Text
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Genre:
  Journal Article
• Place as Subject:
  United States
• Pages in Document:
  myaf049(8 pdf pages)
• Volume:
  63
• Issue:
  6
• Download URL:
  https://stacks.cdc.gov/view/cdc/261367/cdc_261367_DS1.pdf
• File Type:
  [PDF - 79.96 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:92d36856481faa7b98b98f3dc125c9d01d88728f01ce3db35a770233b55690c9296f122c87831e5e3fe6787991c384740f1723483d771c06713207be4c29464c